Literature DB >> 19326161

Optimization of ultrasound array designs for high intensity focused treatment of prostate cancer and benign prostatic hyperplasia.

Khaldon Lweesy1, Luay Fraiwan, Osama Al-Bataineh, Naser Hamdi, Hartmut Dickhaus.   

Abstract

This paper describes the optimization of designing a two-dimensional (2-D) ultrasound phased array to be used for the treatment of both prostate cancer and benign prostatic hyperplasia. The optimization study took into consideration the physical constraints of the conventional method of treatment, and arrived at an optimized array design with the overall dimensions of 10 cm x 2.2 cm. The optimization study also addressed the following additional parameters: The maximum possible depth of penetration (DOP), the maximum possible steering angle, the Grating lobe level, the operating frequency, and the element size. In optimizing the design, the DOP and the steering angle are maximized while the grating lobe value is minimized. A 56 x 12 element 2-D array was found to be the optimum choice allowing both focusing and steering within the entire prostate without inducing damage at locations other than that of the focal point.

Entities:  

Mesh:

Year:  2009        PMID: 19326161     DOI: 10.1007/s11517-009-0478-4

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  8 in total

1.  The feasibility of MRI-guided whole prostate ablation with a linear aperiodic intracavitary ultrasound phased array.

Authors:  S D Sokka; K H Hynynen
Journal:  Phys Med Biol       Date:  2000-11       Impact factor: 3.609

2.  Two-dimensional ultrasound phased array design for tissue ablation for treatment of benign prostatic hyperplasia.

Authors:  K Y Saleh; N B Smith
Journal:  Int J Hyperthermia       Date:  2004-02       Impact factor: 3.914

3.  Design and experiment of 256-element ultrasound phased array for noninvasive focused ultrasound surgery.

Authors:  Mingzhu Lu; Mingxi Wan; Feng Xu; Xiaodong Wang; Xiaozhen Chang
Journal:  Ultrasonics       Date:  2006-08-11       Impact factor: 2.890

4.  Design and optimization of an aperiodic ultrasound phased array for intracavitary prostate thermal therapies.

Authors:  E B Hutchinson; M T Buchanan; K Hynynen
Journal:  Med Phys       Date:  1996-05       Impact factor: 4.071

5.  Microwave applicator for transurethral hyperthermia of benign prostatic hyperplasia.

Authors:  M A Astrahan; M D Sapozink; D Cohen; G Luxton; T D Kampp; S Boyd; Z Petrovich
Journal:  Int J Hyperthermia       Date:  1989 May-Jun       Impact factor: 3.914

6.  1.5-D high intensity focused ultrasound array for non-invasive prostate cancer surgery.

Authors:  L Curiel; F Chavrier; R Souchon; A Birer; J Y Chapelon
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2002-02       Impact factor: 2.725

7.  Arrays of multielement ultrasound applicators for interstitial hyperthermia.

Authors:  R J Lee; M Buchanan; L J Kleine; K Hynynen
Journal:  IEEE Trans Biomed Eng       Date:  1999-07       Impact factor: 4.538

8.  A 63 element 1.75 dimensional ultrasound phased array for the treatment of benign prostatic hyperplasia.

Authors:  Khaldon Y Saleh; Nadine Barrie Smith
Journal:  Biomed Eng Online       Date:  2005-06-17       Impact factor: 2.819

  8 in total
  4 in total

1.  Design and ex vivo kidney evaluation of a high-intensity focused ultrasound transducer and 3D positioner.

Authors:  Khaldon Lweesy; Luay Fraiwan; Alaa Shatat; Ghassan Abdo; Abduallah Dawodiah; Mohammad Sameer
Journal:  Med Biol Eng Comput       Date:  2009-12-10       Impact factor: 2.602

2.  Local property characterization of prostate glands using inhomogeneous modeling based on tumor volume and location analysis.

Authors:  Yeongjin Kim; Bummo Ahn; Jae Won Lee; Koon Ho Rha; Jung Kim
Journal:  Med Biol Eng Comput       Date:  2012-11-11       Impact factor: 2.602

3.  Design aspects of focal beams from high-intensity arrays.

Authors:  Douglas Stephens; Dustin Kruse; Shengping Qin; Katherine Ferrara
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2011-08       Impact factor: 2.725

4.  Low‑frequency ultrasound and microbubbles combined with simvastatin promote the apoptosis of MCF‑7 cells by affecting the LATS1/YAP/RHAMM pathway.

Authors:  Haige Li; Chen Chen; Dehang Wang
Journal:  Mol Med Rep       Date:  2018-07-12       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.